MHC-mismatched mice liver transplantation promotes tumor growth in liver graft

S. Yan, Y. Ding, Y. Tian, Z. Lu, Y. Wang, Q. Zhang, Y. Ye, L. Zhou, H. Xie, H. Chen, Minghao Zheng, S. Zheng

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)


Liver transplantation is a final therapeutic option for treatment of hepatic malignancies, but local recurrence remains high after surgery. However, the underlying mechanisms of local tumor recurrence are still unknown. We speculated that immunological status of transplanted liver may contribute to the progress of tumor development. CT-26 tumor cells are injected into graft after allogeneic or syngeneic liver transplantation. The growth pattern of tumor and the co-relationship of regulatory T cell and effector T cells in liver graft were observed and investigated at 3d, 6d, 9d and 15d post-transplantation. The Hepatic Replacement Area of tumor in allogeneic grafts was significantly larger than that in syngeneic grafts. The activation of tumor growth in allografts was due to the dysfunction of effector T cells mediated by regulatory T cells in liver graft. Using nude mice model, we further confirmed that regulatory T cells from allograft significantly weaken the function of effector T cells in vivo. Our data has showed that MHC-mismatched mice liver transplantation can promote tumor growth in liver graft. For the first time, we demonstrated that susceptibility to tumor development in liver graft is due to the down-regulation of effector T cells' function mediated by the regulatory T cells. © 2014 Elsevier Ireland Ltd.
Original languageEnglish
Pages (from-to)162-171
JournalCancer Letters
Issue number1
Publication statusPublished - 2014


Dive into the research topics of 'MHC-mismatched mice liver transplantation promotes tumor growth in liver graft'. Together they form a unique fingerprint.

Cite this